Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study

David S Knopman, Rebecca F. Gottesman, A. Richey Sharrett, Amanda L. Tapia, Sonia DavisThomas, B. Gwen Windham, Laura Coker, Andrea L.C. Schneider, Alvaro Alonso, Josef Coresh, Marilyn S. Albert, Thomas H. Mosley

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: The interplay between midlife vascular risk factors and midlife cognitive function with later life mild cognitive impairment (MCI) and dementia (DEM) is not well understood. Methods: In the Atherosclerosis Risk in Communities Study, cardiovascular risk factors and cognition were assessed in midlife, ages 45–64 years. In 2011–2013, 20–25 years later, all consenting Atherosclerosis Risk in Communities participants underwent a cognitive and neurological evaluation and were given adjudicated diagnoses of cognitively normal, MCI, or DEM. Results: In 5995 participants with complete covariate data, midlife diabetes, hypertension, obesity, and hypercholesterolemia were associated with late-life MCI and DEM. Low midlife cognition function was also associated with greater likelihood of late-life MCI or DEM. Both midlife vascular risk factors and midlife cognitive function remained associated with later life MCI or DEM when both were in the model. Discussion: Later life MCI and DEM were independently associated with midlife vascular risk factors and midlife cognition.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Dementia
Atherosclerosis
Cognition
Hypercholesterolemia
Cognitive Dysfunction
vascular factor
Obesity
Hypertension

Keywords

  • APOE
  • Cognition
  • Dementia
  • Diabetes
  • Epidemiology
  • Hypertension
  • Mild cognitive impairment
  • Prevalence

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life : The Atherosclerosis Risk in Communities Study. / Knopman, David S; Gottesman, Rebecca F.; Sharrett, A. Richey; Tapia, Amanda L.; DavisThomas, Sonia; Windham, B. Gwen; Coker, Laura; Schneider, Andrea L.C.; Alonso, Alvaro; Coresh, Josef; Albert, Marilyn S.; Mosley, Thomas H.

In: Alzheimer's and Dementia, 01.01.2018.

Research output: Contribution to journalArticle

Knopman, David S ; Gottesman, Rebecca F. ; Sharrett, A. Richey ; Tapia, Amanda L. ; DavisThomas, Sonia ; Windham, B. Gwen ; Coker, Laura ; Schneider, Andrea L.C. ; Alonso, Alvaro ; Coresh, Josef ; Albert, Marilyn S. ; Mosley, Thomas H. / Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life : The Atherosclerosis Risk in Communities Study. In: Alzheimer's and Dementia. 2018.
@article{d4b7aad0a105433b904ff59c30ba356a,
title = "Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study",
abstract = "Introduction: The interplay between midlife vascular risk factors and midlife cognitive function with later life mild cognitive impairment (MCI) and dementia (DEM) is not well understood. Methods: In the Atherosclerosis Risk in Communities Study, cardiovascular risk factors and cognition were assessed in midlife, ages 45–64 years. In 2011–2013, 20–25 years later, all consenting Atherosclerosis Risk in Communities participants underwent a cognitive and neurological evaluation and were given adjudicated diagnoses of cognitively normal, MCI, or DEM. Results: In 5995 participants with complete covariate data, midlife diabetes, hypertension, obesity, and hypercholesterolemia were associated with late-life MCI and DEM. Low midlife cognition function was also associated with greater likelihood of late-life MCI or DEM. Both midlife vascular risk factors and midlife cognitive function remained associated with later life MCI or DEM when both were in the model. Discussion: Later life MCI and DEM were independently associated with midlife vascular risk factors and midlife cognition.",
keywords = "APOE, Cognition, Dementia, Diabetes, Epidemiology, Hypertension, Mild cognitive impairment, Prevalence",
author = "Knopman, {David S} and Gottesman, {Rebecca F.} and Sharrett, {A. Richey} and Tapia, {Amanda L.} and Sonia DavisThomas and Windham, {B. Gwen} and Laura Coker and Schneider, {Andrea L.C.} and Alvaro Alonso and Josef Coresh and Albert, {Marilyn S.} and Mosley, {Thomas H.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jalz.2018.03.011",
language = "English (US)",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life

T2 - The Atherosclerosis Risk in Communities Study

AU - Knopman, David S

AU - Gottesman, Rebecca F.

AU - Sharrett, A. Richey

AU - Tapia, Amanda L.

AU - DavisThomas, Sonia

AU - Windham, B. Gwen

AU - Coker, Laura

AU - Schneider, Andrea L.C.

AU - Alonso, Alvaro

AU - Coresh, Josef

AU - Albert, Marilyn S.

AU - Mosley, Thomas H.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: The interplay between midlife vascular risk factors and midlife cognitive function with later life mild cognitive impairment (MCI) and dementia (DEM) is not well understood. Methods: In the Atherosclerosis Risk in Communities Study, cardiovascular risk factors and cognition were assessed in midlife, ages 45–64 years. In 2011–2013, 20–25 years later, all consenting Atherosclerosis Risk in Communities participants underwent a cognitive and neurological evaluation and were given adjudicated diagnoses of cognitively normal, MCI, or DEM. Results: In 5995 participants with complete covariate data, midlife diabetes, hypertension, obesity, and hypercholesterolemia were associated with late-life MCI and DEM. Low midlife cognition function was also associated with greater likelihood of late-life MCI or DEM. Both midlife vascular risk factors and midlife cognitive function remained associated with later life MCI or DEM when both were in the model. Discussion: Later life MCI and DEM were independently associated with midlife vascular risk factors and midlife cognition.

AB - Introduction: The interplay between midlife vascular risk factors and midlife cognitive function with later life mild cognitive impairment (MCI) and dementia (DEM) is not well understood. Methods: In the Atherosclerosis Risk in Communities Study, cardiovascular risk factors and cognition were assessed in midlife, ages 45–64 years. In 2011–2013, 20–25 years later, all consenting Atherosclerosis Risk in Communities participants underwent a cognitive and neurological evaluation and were given adjudicated diagnoses of cognitively normal, MCI, or DEM. Results: In 5995 participants with complete covariate data, midlife diabetes, hypertension, obesity, and hypercholesterolemia were associated with late-life MCI and DEM. Low midlife cognition function was also associated with greater likelihood of late-life MCI or DEM. Both midlife vascular risk factors and midlife cognitive function remained associated with later life MCI or DEM when both were in the model. Discussion: Later life MCI and DEM were independently associated with midlife vascular risk factors and midlife cognition.

KW - APOE

KW - Cognition

KW - Dementia

KW - Diabetes

KW - Epidemiology

KW - Hypertension

KW - Mild cognitive impairment

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=85049300280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049300280&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2018.03.011

DO - 10.1016/j.jalz.2018.03.011

M3 - Article

C2 - 29763593

AN - SCOPUS:85049300280

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

ER -